Zobrazeno 1 - 10
of 24
pro vyhledávání: '"M.H.G. Rep"'
Autor:
Hans M. Schrijver, Thea van Lopik, René A. W. van Lier, H.J. Adèr, Chris H. Polman, M.H.G. Rep, Rogier Q Hintzen, Marijke T. L. Roos
Publikováno v:
Journal of Neuroimmunology, 96, 92-100. Elsevier
Journal of neuroimmunology, 96(1), 92-100. Elsevier
Rep, M H G, Schrijver, H M, van Lopik, T, Hintzen, R Q, Roos, M T L, Ader, H J, Polman, C H & van Lier, R A W 1999, ' Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients ', Journal of Neuroimmunology, vol. 96, pp. 92-100 . https://doi.org/10.1016/S0165-5728(98)00271-9
Journal of neuroimmunology, 96(1), 92-100. Elsevier
Rep, M H G, Schrijver, H M, van Lopik, T, Hintzen, R Q, Roos, M T L, Ader, H J, Polman, C H & van Lier, R A W 1999, ' Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients ', Journal of Neuroimmunology, vol. 96, pp. 92-100 . https://doi.org/10.1016/S0165-5728(98)00271-9
Interferon (IFN)-beta has been shown to favorably alter the disease course of relapsing-remitting multiple sclerosis (RRMS) patients. Although its mode of action is still unclear, there is ample evidence from in vitro studies that IFN-beta directly m
Autor:
René A. W. van Lier, M.H.G. Rep, Michèl R. Klein, Susana R. Kerkhof-Garde, Paul A. Baars, Dörte Hamann, Berend Hooibrink
Publikováno v:
Journal of experimental medicine, 186(9), 1407-1418. Rockefeller University Press
Journal of Experimental Medicine, 186, 1407-1418. Rockefeller University Press
The Journal of Experimental Medicine
Journal of Experimental Medicine, 186, 1407-1418. Rockefeller University Press
The Journal of Experimental Medicine
Human CD8+ memory- and effector-type T cells are poorly defined. We show here that, next to a naive compartment, two discrete primed subpopulations can be found within the circulating human CD8+ T cell subset. First, CD45RA-CD45R0(+) cells are remini
Autor:
R. A. W. Van Lier, Chris H. Polman, Marijke T. L. Roos, M.H.G. Rep, Herman J. Adèr, B.W. van Oosten
Publikováno v:
Rep, M H G, Van Oosten, B W, Roos, M T L, Adèr, H J, Polman, C H & Van Lier, R A W 1997, ' Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-γ secreting TH1 cells in humans ', Journal of Clinical Investigation, vol. 99, no. 9, pp. 2225-2231 . https://doi.org/10.1172/JCI119396
The journal of clinical investigation, 99, 2225-2231. The American Society for Clinical Investigation
Journal of Clinical Investigation, 99(9), 2225-2231. The American Society for Clinical Investigation
Journal of clinical investigation, 99(9), 2225-2231. The American Society for Clinical Investigation
The journal of clinical investigation, 99, 2225-2231. The American Society for Clinical Investigation
Journal of Clinical Investigation, 99(9), 2225-2231. The American Society for Clinical Investigation
Journal of clinical investigation, 99(9), 2225-2231. The American Society for Clinical Investigation
CD4(pos) TH1 T cells are considered to play a central role in a number of human autoimmune diseases such as rheumatoid arthritis (RA) and multiple sclerosis. Experimental treatment protocols aimed at selectively eliminating CD4(pos) T cells thus far
Autor:
R. A. W. Van Lier, Chris H. Polman, B.W. van Oosten, Petra E.T. Scholten, Hans-Peter Hartung, M.H.G. Rep, K.W. Pflughaupt, H.J. Adèr, B.M.E. von Blomberg
Publikováno v:
Journal of neuroimmunology, 66(1-2), 49-55. Elsevier
Journal of Neuroimmunology, 66(1-2), 49-55. Elsevier
Van Oosten, B W, Rep, M H G, Van Lier, R A W, Scholten, P E T, Von Blomberg, B M E, Pflughaupt, K W, Hartung, H P, Adèr, H J & Polman, C H 1996, ' A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis ', Journal of Neuroimmunology, vol. 66, no. 1-2, pp. 49-55 . https://doi.org/10.1016/0165-5728(96)00019-7
Journal of Neuroimmunology, 66(1-2), 49-55. Elsevier
Van Oosten, B W, Rep, M H G, Van Lier, R A W, Scholten, P E T, Von Blomberg, B M E, Pflughaupt, K W, Hartung, H P, Adèr, H J & Polman, C H 1996, ' A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis ', Journal of Neuroimmunology, vol. 66, no. 1-2, pp. 49-55 . https://doi.org/10.1016/0165-5728(96)00019-7
Multiple sclerosis is probably mainly mediated by T-helper 1 (T(H)l)-lymphocytes. T(H)1-function can be down-regulated in vitro and in animal experiments by pentoxifylline. Therefore, we included 20 multiple sclerosis patients in an open label pilot
Autor:
R. Q. Hintzen, R. A. W. Van Lier, Chris H. Polman, Hans Link, U. Fiszer, M.H.G. Rep, Sten Fredrikson
Publikováno v:
Journal of neuroimmunology, 56(1), 99-105. Elsevier
Within the peripheral blood, CD4+CD27- T cells only reside within the CD45RA- (memory or primed) T cell subset. Cells with this phenotype have characteristics of specialized effector T cells according to their cytokine secretion profiles and the expr
Publikováno v:
Journal of Neuroimmunology. 52:139-146
Function and phenotype of peripheral blood (PB) T cells in multiple sclerosis (MS) patients were analyzed. In whole blood cultures, T cell proliferation of multiple sclerosis (MS) patients, using soluble CD3 mAb and CD2 mAb as stimulants, was reduced
Publikováno v:
Immunobiology. 180:295-307
The influence of recirculating lymphocytes on the function and morphology of high endothelial venules (HEV) has been studied. Mice were depleted of lymphocytes by lethal (1200 cGy) total body irradiation; subsequently, the HEV in mesenteric and cervi
Autor:
B.M.J. Uitdehaag, Frederik Barkhof, M.H.G. Rep, Chris H. Polman, J. F. Meilof, Joep Killestein, R. A. W. Van Lier, H.J. Adèr
Publikováno v:
Neurology, 58(7), 1077-1080. Lippincott Williams and Wilkins
Scopus-Elsevier
Scopus-Elsevier
Background: The exact mechanisms by which T cells contribute to MS progression are not known. Recently, the results of cross-sectional studies suggested seasonal variation of both interferon (IFN)- production and the number of active MRI lesions in M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8295643e912d49be9c4b75f9b847364b
https://pure.amc.nl/en/publications/seasonal-variation-in-immune-measurements-and-mri-markers-of-disease-activity-in-ms(a838e351-bfe9-40be-952f-e25645956c34).html
https://pure.amc.nl/en/publications/seasonal-variation-in-immune-measurements-and-mri-markers-of-disease-activity-in-ms(a838e351-bfe9-40be-952f-e25645956c34).html
Autor:
Frederik Barkhof, Chris H. Polman, R. A. W. Van Lier, H.J. Adèr, Joep Killestein, M.H.G. Rep, Marijke T. L. Roos
Publikováno v:
Journal of neuroimmunology, 118(2), 286-294. Elsevier
Background : The role of T cell subpopulations and their ability to produce immunoregulatory cytokines has been extensively studied in multiple sclerosis (MS). However, the exact mechanisms by which T cells and cytokines contribute to disease activit
Publikováno v:
Journal of neuroimmunology. 67(2)
Results from recent clinical trials have indicated that recombinant interferon-beta (rIFN-beta) is a promising drug for the treatment of Multiple Sclerosis (MS), a disease of supposed autoimmune etiology. To gain insight into the immunoregulatory pro